Clinical Trials Logo

Depressive Disorder clinical trials

View clinical trials related to Depressive Disorder.

Filter by:

NCT ID: NCT03113201 Completed - Depression Clinical Trials

Collabri Flex - Effect of Collaborative Care for People With Depression in General Practice

Collabri Flex
Start date: January 15, 2018
Phase: N/A
Study type: Interventional

The aim of the study Collabri Flex is to: - Develop a Danish model for collaborative care for patients with depression in general practice, based on past experience gained in the Collabri Project. - Examine the impact of this model compared with liaison-consultation for people with depression in a randomized controlled design from selected endpoints.

NCT ID: NCT03110016 Completed - Clinical trials for Subthreshold Depression

Smartphone Intervention for Subthreshold Depression

Start date: May 16, 2017
Phase: N/A
Study type: Interventional

The study aimed to examine the feasibility, usability, user satisfaction, safety, and preliminary efficacy of a smartphone application intervention for young adults with subthreshold depression.

NCT ID: NCT03109717 Completed - Clinical trials for Treatment Resistant Depression

Structural and Functional Connectivity of Brainstem Monoamine Pathways in Treatment Resistant Depression

MAOI
Start date: July 2016
Phase:
Study type: Observational

Study TRD subjects' resistance to at least 2 different antidepressants, we hypothesize that because of their significant depression and treatment resistant status they are most likely to exhibit BSMN pathway abnormalities.

NCT ID: NCT03109002 Completed - Clinical trials for Depressive Disorder, Treatment-Resistant

An Epidemiology Study of Treatment Resistant Depression in the United States (US)

Start date: January 15, 2017
Phase:
Study type: Observational

The purpose of this study is to describe the epidemiology of Treatment Resistant Depression (TRD) in the US, including the population incidence of TRD, and TRD as a proportion of Pharmacologically Treated Depression (PTD), and stratify the estimates by sex and age group, with separate estimates for the Medicaid population, the Medicare population, and the privately insured population. Anonymized participants data will be used for the analysis.

NCT ID: NCT03108625 Completed - Clinical trials for Depressive Disorder, Major

Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age

Start date: March 1, 2017
Phase: Phase 3
Study type: Interventional

Evaluation of the long-term safety and tolerability of vortioxetine in child and adolescent patients with a Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5™) diagnosis of MDD

NCT ID: NCT03106883 Completed - Depression Clinical Trials

Affective Attentional Bias Training In Depression

Start date: January 30, 2017
Phase: N/A
Study type: Interventional

Biased attention toward negatively valenced information has been considered as a mechanism for risk and relapse in depression. Those with depression tend to focus their visual attention first, more frequently, and for longer periods of time, if it connotes negative (particularly sad) mood. To this end, investigators have recently discovered that this bias might be modifiable. However, the existing literature is mixed with regard to effectiveness. The investigators propose in this study a novel approach to modifying attention bias in depression by using real time feedback with eye tracking technology. The investigators will examine if, compared to a sham condition, rewarding attention toward positive stimuli results in improved mood and reductions in attention bias. Following three sessions of either sham training or active attentional bias training, the investigators hypothesize that participants in the active training condition will experience a) reductions in negative attentional bias, and b) to an improved mood state and increased quality of life, compared to those in the sham training condition.

NCT ID: NCT03105700 Completed - Epilepsy Clinical Trials

Low Frequency TMS for Depression in Epilepsy

LFTMS
Start date: April 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if low-frequency transcranial magnetic stimulation (TMS) is safe and feasible for treating depressive symptoms in patients with epilepsy. Patients will receive an accelerated protocol of TMS consisting of three consecutive days of treatment. Patients will have in-person follow up visits after one month and again after six months.

NCT ID: NCT03103165 Completed - Depression Clinical Trials

SimCoach Evaluation: : A Virtual Human Intervention to Encourage Servicemember Help-seeking for PTSD and Depression

Start date: October 2012
Phase: N/A
Study type: Interventional

SimCoach, a computer program featuring a virtual human that speaks and gestures in a videogame-like interface, is designed to encourage servicemembers to seek help to improve their psychological health.

NCT ID: NCT03102736 Completed - Depression Clinical Trials

Ketamine and Nitroprusside for Depression

Start date: February 14, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test the effects of the medication ketamine and the medication called nitroprusside in patients with major depression. Ketamine has both good and bad effects. Some studies have shown that ketamine improves depression. However, studies have also shown that it causes strange and sometimes unpleasant sensations referred to "psychotic" or "dissociative" symptoms. An example of a psychotic symptom would be hearing or seeing something that in reality is not there. The study team would like to see if nitroprusside can prevent the reported bad effects of ketamine without blocking the reported good effects. This might make ketamine a better treatment for depression.

NCT ID: NCT03100981 Completed - Prostate Cancer Clinical Trials

Online Mindfulness for Women Treated for Breast Cancer and Men Treated for Prostate Cancer

Start date: February 24, 2016
Phase: N/A
Study type: Interventional

AIM: The aim of the present study is to investigate if Internet-delivered Mindfulness-Based Cognitive Therapy (I-MBCT) can reduce symptoms of depression and anxiety among women treated for breast cancer and men treated for prostate cancer compared to a treatment as usual control group. Furthermore, the effect of I-MBCT on symptoms of stress, insomnia, quality of life, and self-compassion and the potential mediating effect of working alliance and mindfulness will be explored. Finally, the cost-effectiveness of the I-MBCT intervention will be explored. BACKGROUND: Symptoms of depression, anxiety, and stress are prevalent late-effects among cancer patients and -survivors. Mindfulness-based interventions aim at improving affect tolerance and emotion regulation, which could be of particular relevance for cancer patients and survivors, and MBCT has been shown efficacious in treating symptoms of depression, anxiety, and stress among cancer patients and survivors. However, the availability of face-to-face delivered MBCT is limited and hence using the internet to deliver MBCT may be a cost-effective way of increasing the accessibility of the intervention to vulnerable patients with limited resources. METHODS: A total of 155 participants will be recruited from Department of Oncology and Department of Urology at Aarhus University Hospital and randomized to two groups: I-MBCT and a treatment-as-usual wait-list control group. Assessments will be conducted at pre-, midway and post intervention and at a 6- months follow-up.